Home/Filings/4/0000914190-15-000402
4//SEC Filing

Cardiovascular Systems Inc 4

Accession 0000914190-15-000402

CIK 0001180145operating

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:38 PM ET

Size

13.5 KB

Accession

0000914190-15-000402

Insider Transaction Report

Form 4
Period: 2015-09-01
Martin David
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2015-09-01$23.99/sh15,505$371,909462,959 total
  • Sale

    Common Stock

    2015-09-02$23.13/sh4,141$95,772458,818 total
Holdings
  • Common Stock

    (indirect: By Children)
    350
  • Common Stock

    (indirect: By Children)
    850
  • Stock Option (right to buy)

    Exercise: $7.90Exp: 2017-06-11Common Stock (90,580 underlying)
    90,580
  • Stock Option (right to buy)

    Exercise: $12.15Exp: 2017-12-11Common Stock (234,395 underlying)
    234,395
  • Common Stock

    (indirect: By Children)
    850
  • Stock Option (right to buy)

    Exercise: $8.75Exp: 2019-03-01Common Stock (32,350 underlying)
    32,350
Footnotes (4)
  • [F1]Represents shares sold pursuant to a Rule 10b5-1 trading plan, the proceeds of which were used to pay required withholding taxes in connection with the vesting and delivery of restricted stock.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.38 to $24.31 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.08 to $23.21 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Fully exercisable.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001180145

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:38 PM ET
Size
13.5 KB